Texas Bank & Trust’s AbbVie ABBV Stock Holding History

Texas Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	5,258 +1,237	+31%	+$266K	0.43%	56
2026 Q1	$875K	Sell	4,021 -926	-19%	-$205K	0.33%	81
2025 Q4	$1.13M	Sell	4,947 -55	-1%	-$12.5K	0.41%	63
2025 Q3	$1.16M	Buy	5,002 +509	+11%	+$104K	0.44%	61
2025 Q2	$834K	Sell	4,493 -1,896	-30%	-$352K	0.33%	83
2025 Q1	$1.34M	Buy	6,389 +47	+0.7%	+$9.14K	0.57%	44
2024 Q4	$1.13M	Buy	+6,342	New	+$1.17M	0.46%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Texas Bank & Trust's ABBV Position: Q2 2026 in Review

Texas Bank & Trust increased its AbbVie (ABBV) stake by 31% in Q2 2026, buying an estimated $266K and bringing the position to 5,258 shares worth $1.32M. The position accounts for 0.43% of the portfolio, ranked #56.

Texas Bank & Trust first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.34M in Q1 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Texas Bank & Trust held 5,258 shares of AbbVie worth $1.32M as of Q2 2026.
Texas Bank & Trust bought 1,237 AbbVie shares in Q2 2026, an estimated $266K.
AbbVie made up 0.43% of Texas Bank & Trust's portfolio in Q2 2026, its #56 holding.
Texas Bank & Trust first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Texas Bank & Trust's AbbVie position peaked at $1.34M in Q1 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.